The majority of these studies have focussed on solid tumors, however there are reports in haematological malignancies including multiple myeloma [26] and T-ALL [45], and we have previously reported a role for SphK2 in B lineage ALL [30] using a BCR/ABL1-dependent model. This evidence concerns the gene BCR and plasma cell myeloma.